The Carlyle Group
CG
36.00
-1.67
-4.43%
The Carlyle Group
US · CG
#1171 by market cap
Listed 1970
36.00
-1.67
-4.43%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
The Carlyle Group Options Spot-On: On November 19th, 117.35K Contracts Were Traded, With 116.87K Open InterestMarket Newswire · 2026/11/20
-
Rating change
Major Bank Ratings | UBS Group: Lowers Carlyle Target Price to $47, Downgrades Rating to “Neutral”Gelonghui Finance · 2026/11/11
-
Company notice
RCECAP: Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - CG (L) FOUNDATIONBursa Malaysia · 2026/10/29
-
Rating change
Carlyle Group Price Target Cut to $58.00/Share From $66.00 by Goldman SachsDow Jones · 2026/11/11
-
Rating change
Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $102Market Newswire · 2026/11/13
-
Rating change
Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $117Market Newswire · 2026/11/18
-
Company notice
Dynamic Map Platform Co.,Ltd.: Dynamic Map Platform to Exhibit at Tokyo Game Show 2026; Engages in Information Exchange with 35 Domestic and International Companies in the Gaming, CG, and XR Sectors, Proposing the Utilization of Spatial Data for Games.JPX · 2026/9/25
-
The Carlyle Group To Go Ex-Dividend On November 16th, 2026 With 0.35 USD Dividend Per ShareMarket Newswire · 2026/11/13
-
Company notice
4: Statement of changes in beneficial ownership of securities-10% Owner Carlyle Group Inc.SEC · 2026/11/20
-
Rating change
A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $97 to $115Market Newswire · 2026/11/17
-
Company notice
CG MedTech Co: Report on Status of Specific Securities, Etc. Owned by Executives and Major ShareholdersOPENDART · 2026/10/15
-
Carlyle Group, CVC DIF Get EU Approval for BauWatch AcquisitionMT Newswires · 2026/11/11
-
Rating change
Wedbush Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $91Market Newswire · 2026/11/17
-
Rating change
Guggenheim Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $120Market Newswire · 2026/11/19
-
Rating change
Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating, Announces Target Price $100Market Newswire · 2026/11/17
-
KKR and Carlyle Group Invest $475 Million in Litmus Music -- WSJWSJ · 2026/11/18
-
Rating change
Carlyle Group Is Maintained at Buy by Goldman SachsDow Jones · 2026/11/11
-
Rating change
Carlyle Group Cut to Neutral From Buy by UBSDow Jones · 2026/11/10
-
Goldman Sachs Maintains The Carlyle Group(CG.US) With Buy Rating, Cuts Target Price to $58Market Newswire · 2026/11/11
-
Company notice
AMBANK: Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - CG (L) FOUNDATIONBursa Malaysia · 2026/10/29
-
The Carlyle Group To Go Ex-Dividend On November 16th, 2026 With 0.35 USD Dividend Per ShareMarket Newswire · 2026/11/7
-
Company notice
CG MedTech Co: Report on Significant Holdings of Stocks, Etc. (General)OPENDART · 2026/9/11
-
Rating change
Deutsche Bank Adjusts Carlyle Group Price Target to $48 From $51, Maintains Buy RatingMT Newswires · 2026/11/6
-
Evercore ISI Group Maintains In-Line on Carlyle Group, Lowers Price Target to $42Benzinga · 2026/11/6
-
Rating change
Carlyle Group Is Maintained at Overweight by Piper SandlerDow Jones · 2026/10/19
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:19 · For reference only, not investment advice and not tailored to your situation.
The Carlyle Group discussion 0 comments